Parenteral Drugs (India) Ltd Quarterly Results
Q4 FY21-22 Results Summary
Revenue
The revenue stands at ₹1.77 crore, reflecting a quarter-on-quarter *(QoQ) increase of 22.92 per cent from ₹1.44 crore. This corresponds to a year-on-year *(YoY) decline of 31.13 per cent.
Operating Profit
Operating Profit stands at ₹-5.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 82.35 per cent from ₹-3.23 crore. This corresponds to a year-on-year *(YoY) decline of 273.75 per cent.
PBDT
PBDT stands at ₹46.36 crore, reflecting a quarter-on-quarter *(QoQ) increase of 216.22 per cent from ₹-39.89 crore. This corresponds to a year-on-year *(YoY) growth of 259.64 per cent.
Profit Before Tax
Profit Before Tax stands at ₹19.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 143.44 per cent from ₹-44.22 crore. This corresponds to a year-on-year *(YoY) growth of 157.58 per cent.
Net Profit
Net Profit stands at ₹23.81 crore, reflecting a quarter-on-quarter *(QoQ) increase of 168.97 per cent from ₹-34.52 crore. This represents a 195.81 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Parenteral Drugs (India) Ltd Earnings
- YOY
- QOQ
Parenteral Drugs (India) Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Parenteral Drugs (India) Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Parenteral Drugs (India) Ltd Financial Reports
Parenteral Drugs (India) Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Norris Medicines | 4.44% | 6.09% | 0.79% | 2.62% | -19.51% | -25.42% |
| Ortin Global | -3.56% | -9.78% | 18.84% | 0.35% | 30.45% | 46.54% |
| Beryl Drugs | -0.09% | -5.38% | 11.21% | 11.26% | 1.41% | 16.97% |
| Unjha Formul. | 0.00% | -1.50% | -1.01% | -5.29% | -21.45% | -17.81% |
| Hind.Bio Science | 0.39% | -6.91% | -16.43% | 2.40% | 26.11% | -16.07% |
| Colinz Labs | 2.88% | -11.66% | 20.18% | 33.40% | 11.27% | 0.59% |
| Decipher Labs | -0.73% | -2.16% | -5.95% | 11.48% | -28.35% | -39.82% |
Company Info
Company Information
Chairman : Manoharlal Gupta
Whole-time Director : Govind Das Garg
Independent Director : Dharam Pal Khanna
Independent Director : Dilip Kumar Sinha
Non Executive Director : Anil Mittal
Independent Director : Manish Verma
Managing Director & CFO : Vinod Kumar Gupta
Independent Director : Deepali Garhewal
Independent Director : Chhaya Gupta